In conclusion, these findings highlight the potential of complete COX-2 knockout as a therapeutic strategy in GBM, particularly when combined with targeting peripheral macrophages and maintaining a stable microglia population to enhance apoptotic cell clearance and suppress glioblastoma progression. The gene discussed is PTGS2; the disease is glioblastoma.